(2008; 118 pages)
The concept of Essential Medicine in Indonesia was first introduced with the publication of The National List of Essential Medicines (NLEM) in 1978, followed by the National Medicines Policy document in 1983. The National List of Essential Medicines, named DOEN (NLEM) is revised periodically every 3-4 years. DOEN 2008 is a revised edition. The Government’s commitment to do periodic revisions is a reputation of its own.
In the year 2007, the World Health Organization (WHO) has carried out the first phase of Good Governance on Medicines (GGM) program in Indonesia by conducting a survey on transparency of five pharmaceutical functions. One of them is the selection process of essential medicines, which from the aspect of transparency process is valued to be insufficient. From the meeting of the 30th WHO Essential Medicine List in Sri Lanka (2007), it was reiterated that the importance of transparency of the selection process both by expert panel members who do revisions, revision process, and revision methods which have got to be more rely on evidence based medicine (EBM), and the importance of the conflict of interest statement from expert panel members.